Literature DB >> 1974924

Responses of blood vessels in the rabbit knee to electrical stimulation of the joint capsule.

W R Ferrell1, A Khoshbaten.   

Abstract

1. An in vitro preparation of the rabbit knee joint, perfused with oxygenated Locke's solution, was used to study the response of articular blood vessels to electrical stimulation of the joint capsule. 2. Using trains of stimulus pulses of different durations, frequency-response curves were obtained. Electrical stimulation always produced vasoconstriction of joint blood vessels, which increased as a function of both frequency and pulse width. 3. This vasoconstrictor response was neurally mediated as it was markedly inhibited after addition to both bath and perfusate of tetrodotoxin. In addition, the response to field stimulation of the capsule was virtually abolished in animals pretreated with reserpine which depletes sympathetic nerve endings of noradrenaline. 4. The response to electrical stimulation was substantially reduced by the alpha-adrenergic antagonist phenoxybenzamine (10(-5) M), the alpha 1-blocker prazosin (10(-6) M), and by guanethidine (10(-5) M) which inhibits the release of noradrenaline, ATP and neuropeptide Y from sympathetic nerve endings. 5. The attenuation of the vasoconstrictor response to field stimulation by prazosin (10(-6) M) was little altered by addition of the alpha 2-adrenoceptor blocker rauwolscine (10(-6) M) to the perfusate. 6. alpha, beta-Methylene ATP (10(-6) M), a P2-purinoceptor desensitizer, had no effect on the vasoconstrictor response to electrical stimulation. 7. These results indicate that the vasoconstrictor response to electrical stimulation of the rabbit knee joint capsule is mediated via noradrenaline acting upon alpha 1-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974924      PMCID: PMC1189775          DOI: 10.1113/jphysiol.1990.sp018040

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  24 in total

1.  Purinergic inhibition of adrenergic transmission in rabbit blood vessels.

Authors:  C Su
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

2.  Modes of vasoconstrictor and vasodilator neurotransmission.

Authors:  C Su
Journal:  Blood Vessels       Date:  1978

3.  The possibility that adenosine triphosphate is an excitatory transmitter in guinea-pig seminal vesicle.

Authors:  H Nakanishi; H Takeda
Journal:  Jpn J Pharmacol       Date:  1972-04

4.  Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle.

Authors:  G D Hirst; T O Neild
Journal:  Nature       Date:  1980-02-21       Impact factor: 49.962

5.  Effect of adenosine on adrenergic neurotransmission in the superfused rat portal vein.

Authors:  R D Moylan; T C Westfall
Journal:  Blood Vessels       Date:  1979

6.  Effect of chronic denervation on the activities of monoamine oxidase and catechol-O-methyl transferase and on the contents of noradrenaline and adenosine triphosphate in the rabbit ear artery.

Authors:  R J Head; R E Stitzel; I S de la Lande; S M Johnson
Journal:  Blood Vessels       Date:  1977

7.  Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP.

Authors:  J De Mey; G Burnstock; P M Vanhoutte
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

8.  Inhibition of noradrenaline release by adenosine.

Authors:  A R Wakade; T D Wakade
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

9.  The postjunctional effects and neural release of purine compounds in the guinea-pig vas deferens.

Authors:  D P Westfall; R E Stitzel; J N Rowe
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

10.  Neurogenic release of purine compounds in blood vessels.

Authors:  C Su
Journal:  J Pharmacol Exp Ther       Date:  1975-10       Impact factor: 4.030

View more
  9 in total

1.  Fiber bundle-based integrated platform for wide-field fluorescence imaging and patterned optical stimulation for modulation of vasoconstriction in the deep brain of a living animal.

Authors:  Minkyung Kim; Jinki Hong; Jinsik Kim; Hyun-Joon Shin
Journal:  Biomed Opt Express       Date:  2017-05-01       Impact factor: 3.732

2.  Sympathetic innervation and alpha-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint.

Authors:  H Najafipour; W R Ferrell
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

3.  Quantitative analysis of the sympathetic innervation of the rat knee joint.

Authors:  M G Catre; P T Salo
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

4.  Alterations in cat knee joint blood flow induced by electrical stimulation of articular afferents and efferents.

Authors:  A Khoshbaten; W R Ferrell
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

5.  Acute joint inflammation alters the adrenoceptor profile of synovial blood vessels in the knee joints of rabbits.

Authors:  E Gray; W R Ferrell
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

6.  Changes in synovial PO2 and blood flow in the rabbit knee joint due to stimulation of the posterior articular nerve.

Authors:  W R Ferrell; H Najafipour
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

7.  Vasoconstriction by electrical stimulation: new approach to control of non-compressible hemorrhage.

Authors:  Yossi Mandel; Richard Manivanh; Roopa Dalal; Phil Huie; Jenny Wang; Mark Brinton; Daniel Palanker
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Mechanisms of electrical vasoconstriction.

Authors:  Mark Brinton; Yossi Mandel; Ira Schachar; Daniel Palanker
Journal:  J Neuroeng Rehabil       Date:  2018-05-29       Impact factor: 4.262

9.  Toward the Existence of a Sympathetic Neuroplasticity Adaptive Mechanism Influencing the Immune Response. A Hypothetical View-Part II.

Authors:  Emanuel Bottasso
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.